Quantcast
Channel: Italy Headlines on One News Page [United States]
Viewing all 40166 articles
Browse latest View live

EUR/USD trims losses, still in red below 1.1500

$
0
0
· *The index rebounds from fresh lows in the 1.1435/30 band.*
· *The greenback drops t0 95.80 where it met some dip-buyers.*
· *Italy, US-China trade effervescence continues to drive mood.*

*EUR/USD* tumbled to the 1.1430 region earlier in the session but managed to regain some buying interest and climb as high as the boundaries of 1.1490, where it lost some traction.

*EUR/USD looks to Italy, yields, trade*

Despite the rebound, the pair remains entrenched well into the negative territory so far this week, down for the second session in a row on persistent jitters stemming from Italian politics and a resurgence of the trade effervescence in the US-China trade front.

In fact, yields of the Italian 10-year reference retreated from recent tops and helped spot to regain some ground lost, although the political/fiscal situation in Italy keeps showing no light at the end of the tunnel for the time being.

Speaking about Italy and its dispute with Brussels, FXStreet’s Senior Markets Analyst Joseph Trevisani said: “The EU cannot wait indefinitely for the market to punish Italy for its deficit because the longer and farther Italian bonds fall the greater the chance of Eurozone contagion. Nor and for the same reason, can it condemn outright the Italian choices. Diplomatic language concealing the reality that Italy is a sovereign nation is the only answer”.

On the US-China trade dispute, President Trump was once again on the wires reiterating that China is still not ready to clinch a deal, threatening at the same time to impose fresh tariffs on additional $267 billion of Chinese products.

*EUR/USD levels to watch*

At the moment, the pair is losing 0.15% at 1.1475 facing the next support at 1.1432 (low Oct.9) seconded by 1.1331 (200-week SMA) and finally 1.1299 (2018 low Aug.15). On the flip side, a break above 1.1542 (high Oct.4) would target 1.1561 (10-day SMA) en route to 1.1630 (21-day SMA). Reported by FXstreet.com 6 hours ago.

European Markets Bounced Back From Early Weakness

$
0
0
After a positive start to the day, the European markets quickly slipped into negative territory. The weak performance of the Asian markets, coupled with concerns over Italy, Brexit and rising bond yields weighed on investor sentiment. Reported by RTTNews 6 hours ago.

LVMH: 11% organic revenue growth in the first nine months of 2018

$
0
0
Paris, October 9, 2018

LVMH Moët Hennessy Louis Vuitton, the world's leading luxury products group, recorded a 10% increase in revenue, reaching € 33.1 billion in the first nine months of 2018. Organic revenue grew 11% compared to the same period in 2017, and 13% excluding the impact of the airport concession closures in Hong Kong at the end of 2017. All geographical areas progressed well.

In the third quarter, revenue was up 10% compared to the same period in 2017, a performance which continued the trend recorded in the first half of the year and to which all business groups contributed. Organic revenue growth was 10%.

Revenue by business group:

In million euros *9 months 2018* *9 months 2017* *Change 2018 / 2017*
*First 9 months*
*  Reported           Organic**
Wines & Spirits 3 565 3 514 + 1 % + 7 %
Fashion & Leather Goods 13 052 10 838 + 20 % + 14 %
Perfumes & Cosmetics 4 410 4 065 + 8 % + 14 %
Watches & Jewelry 3 021 2 789 + 8 % + 14 %
Selective Retailing 9 544 9 335 + 2 % + 8 %
Other activities & eliminations (463) (446) ns ns
Total *33 129* *30 095* *+ 10 %* *+ 11 %*

* with comparable structure and constant exchange rates. The exchange rate impact was -5% and the structural impact was + 4% (integration of Christian Dior Couture).

The *Wines & Spirits* business group recorded organic revenue growth of 7% in the first nine months of 2018. Champagne volumes were stable over the period. The prestige vintages performed particularly well while continuing a price increase policy. Hennessy cognac volumes increased by 4%. The US and Chinese markets grew rapidly.

The *Fashion & Leather Goods* business group achieved organic revenue growth of 14% in the first nine months of 2018. Louis Vuitton continues to be driven by the success of its iconic leather goods lines and by exceptional creativity in all its businesses. Ready-to-wear  and shoes, in particular, experienced strong momentum with an excellent reception of the last two fashion shows of Womenswear and Menswear. A new communication for Louis Vuitton perfumes was unveiled, marking the launch of the brand's latest perfume creation. Christian Dior, consolidated since the second half of 2017, enjoyed an excellent performance. Celine made progress and began a new chapter in its history with the first runway show of Hedi Slimane, which was a great success and created enormous resonance. Fendi and Loro Piana continued to grow. The other brands continued to strengthen.

The *Perfumes & Cosmetics* business group recorded organic revenue growth of 14% in the first nine months of 2018, driven in particular by the performance of its star brands. Parfums Christian Dior continued its remarkable progress, driven by the launch of its new perfume Joy and the exceptional worldwide success of Sauvage and its other iconic perfumes, J'adore and Miss Dior. Rouge Dior lipstick also contributed to the performance of the House. Guerlain performed very well, with the success of Abeille Royale in skincare and Rouge G in makeup. Parfums Givenchy continued its expansion, driven by makeup and its new feminine scent L'Interdit. Fresh grew strongly.

In the first nine months of 2018, the *Watches & Jewelry* business group achieved organic revenue growth of 14%. Bvlgari had an excellent performance and gained market share. Its iconic jewelry and watch collections Serpenti, Diva, B.Zero1, Lvcea and Octo showed strong momentum; the new Wild Pop high-end jewelry line, launched at the beginning of the summer, continued to grow. Chaumet and Fred progressed steadily. In the watchmaking sector, TAG Heuer continued to develop its iconic lines. Hublot, which grew strongly, opened its first stand-alone boutique in London.

The *Selective Retailing* business group achieved organic revenue growth of 8% in the first nine months of 2018, and 14% excluding the airport concession closures in Hong Kong. Sephora's  organic revenue growth was strong, particularly in North America and Asia. The expansion and renovation of its distribution network is continuing with a new store concept in China and the first Sephora-branded store in Russia. DFS performed well, especially in Hong Kong and Macao. The recent openings of T Galleria in Cambodia and Italy progressed well.

*OUTLOOK*

In an uncertain geopolitical and monetary context, LVMH will continue to be vigilant. The Group will pursue its strategy focused on innovation and targeted geographic expansion in the most promising markets. LVMH will rely on the power of its brands and the talent of its teams to further extend its global leadership in the luxury market in 2018.

During this quarter and to date, no events or changes have occurred which could significantly modify the Group's financial structure.
Regulated information related to this press release and presentation is available on www.lvmh.com.

*ANNEX*

LVMH - Revenue by business group and by quarter

*2018 Revenue (Euro millions)*
*FY 2018*

  Wines & Spirits Fashion & Leather Goods Perfumes & Cosmetics Watches & Jewelry Selective Retailing Other activities & eliminations *Total*

 
First Quarter 1 195 4 270 1 500 959 3 104 (174) *10 854*
Second Quarter 1 076 4 324 1 377 1 019 3 221 (121) *10 896*
*Total First Half* *2 271* *8 594* *2 877* *1 978* *6 325* *(295)* *21 750*
Third Quarter 1 294 4 458 1 533 1 043 3 219 (168) *11 379*
*Nine months* *3 565* *13 052* *4 410* *3 021* *9 544* *(463)* *33 129*

*2018 Revenue (organic growth versus same period of 2017)*
*FY 2018*

  Wines & Spirits Fashion & Leather Goods Perfumes & Cosmetics Watches & Jewelry Selective Retailing Other activities & eliminations *Total*

 
First Quarter +10% +16% +17% +20% +9% - *+13%*
Second Quarter +3% +13% +14% +12% +9% - *+11%*
*Total First Half* *+7%* *+15%* *+16%* *+16%* *+9%* *-* *+12%*
Third Quarter +7% +14% +11% +10% +5% - *+10%*
*Nine months* *+7%* *+14%* *+14%* *+14%* *+8%* *-* *+11%*

*2017 Revenue (Euro millions)*
*FY 2017*

  Wines & Spirits Fashion & Leather Goods Perfumes & Cosmetics Watches & Jewelry Selective Retailing Other activities & eliminations *Total*

 
First Quarter 1 196  3 405 1 395 879 3 154 (145) * 9 884*
Second Quarter 1 098 *3 494  1 275 959 3 126 (122) **9 830*
*Total First Half* *2 294* *6 899* *2 670* *1 838* *6 280* *(267)* *19 714*
Third Quarter 1 220 3 939 1 395 951 3 055 (179) *10 381*
*Nine months* *3 514* *10 838* *4 065* *2 789* *9 335* *(446)* *30 095*

* Includes all Rimowa revenue for the first half of 2017.

*LVMH*
LVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot Ponsardin, Krug, Ruinart, Mercier, Château d'Yquem, Domaine du Clos des Lambrays, Château Cheval Blanc, Colgin Cellars, Hennessy, Glenmorangie, Ardbeg, Belvedere, Woodinville, Volcán de Mi Tierra, Chandon, Cloudy Bay, Terrazas de los Andes, Cheval des Andes, Cape Mentelle, Newton, Bodega Numanthia and Ao Yun. Its Fashion and Leather Goods division includes Louis Vuitton, Christian Dior Couture, Celine, Loewe, Kenzo, Givenchy, Thomas Pink, Fendi, Emilio Pucci, Marc Jacobs, Berluti, Nicholas Kirkwood, Loro Piana and RIMOWA. LVMH is present in the Perfumes and Cosmetics sector with Parfums Christian Dior, Guerlain, Parfums Givenchy, Kenzo Parfums, Perfumes Loewe, Benefit Cosmetics, Make Up For Ever, Acqua di Parma, Fresh, Fenty Beauty by Rihanna and Maison Francis Kurkdjian. LVMH's Watches and Jewelry division comprises Bvlgari, TAG Heuer, Chaumet, Dior Watches, Zenith, Fred and Hublot. LVMH is also active in selective retailing as well as in other activities through DFS, Sephora, Le Bon Marché, La Samaritaine, Groupe Les Echos, Cova, Le Jardin d'Acclimatation, Royal Van Lent and Cheval Blanc hotels.

"This document may contain certain forward looking statements which are based on estimations and forecasts. By their nature, these forward looking statements are subject to important risks and uncertainties and factors beyond our control or ability to predict, in particular those described in LVMH's Reference Document which is available on the website (www.lvmh.com). These forward looking statements should not be considered as a guarantee of future performance, the actual results could differ materially from those expressed or implied by them. The forward looking statements only reflect LVMH's views as of the date of this document, and LVMH does not undertake to revise or update these forward looking statements. The forward looking statements should be used with caution and circumspection and in no event can LVMH and its Management be held responsible for any investment or other decision based upon such statements. The information in this document does not constitute an offer to sell or an invitation to buy shares in LVMH or an invitation or inducement to engage in any other investment activities."

*LVMH CONTACTS*

*Analysts and investors*
Chris Hollis
LVMH
+ 33 1 4413 2122 *Media*
Jean-Charles Tréhan
LVMH
+ 33 1 4413 2620
* *

*MEDIA CONTACTS * * *
* France*
 Michel Calzaroni, Olivier Labesse, Hugues Schmitt,
 Thomas Roborel de Climens
 DGM Conseil
 + 33 1 4070 1189 *Italy*
Michele Calcaterra, Matteo Steinbach
SEC and Partners
+ 39 02 6249991
*UK*
Hugh Morrison, Charlotte McMullen
Montfort Communications
+ 44 7921 881 800 *US*
James Fingeroth, Molly Morse, Anntal Silver
Kekst & Company
+ 1 212 521 4800

*Attachment*

· PDF Version.pdf Reported by GlobeNewswire 6 hours ago.

After Mayor Is Arrested, Italy’s “Refugee Town” Fights Back

$
0
0
Worldcrunch.com / LA STAMPA

*RIACE* — On October 14, 2016, Riace Mayor Domenico “Mimmo” Lucano took to the stage at the Rendano theater in the city of Cosenza. He was there to accept a prize from a local foundation, awarded for his policy of welcoming migrants and...
** Reported by Worldcrunch 5 hours ago.

Christian Dior : First nine months 2018 revenue

$
0
0
*                                                                                                                                        *
*CHRISTIAN DIOR*
*First nine months 2018 revenue*

The *Christian Dior group* recorded a 6% * increase in revenue, reaching € 33.1 billion in the first nine months of 2018. Organic revenue grew 12% * compared to the same period in 2017, and 14% * excluding the impact of the airport concession closures in Hong Kong at the end of 2017. All geographical areas progressed well.

In the third quarter, revenue was up 10% compared to the same period in 2017, a performance which continued the trend recorded in the first half of the year and to which all business groups contributed. Organic revenue growth was 10%.

Revenue by business group for *the Christian Dior group* was as follows:

*REVENUE*

(EUR millions) *9 months*
*2018* *9 months*
*2017* *Change at actual exchange rates* *  **Organic*
*growth *^(a)
Wines and Spirits *3,565* 3,514 +1% +7%
Fashion and Leather Goods *13,052* 11,885 ^* +10% ^* +15%
Perfumes and Cosmetics *4,410* 4,065 +8% +14%
Watches and Jewelry *3,021* 2,789 +8% +14%
Selective Retailing *9,544* 9,335 +2% +8%
Other activities and eliminations *(463)* (463) ^* - -
*Total* *33,129* *31,125* *+6%* *+12% *^(b)

^(a) On a constant consolidation scope and currency basis                                                                                               
^(b) Exchange rate impact: -5%

^*  Some of the information reported by Christian Dior for the first half of 2017 differs from that reported by LVMH because Christian Dior Couture was not yet included in LVMH's scope of consolidation in the first half of 2017.
The *Wines & Spirits* business group recorded organic revenue growth of 7% in the first nine months of 2018. Champagne volumes were stable over the period. The prestige vintages performed particularly well while continuing a price increase policy. Hennessy cognac volumes increased by 4%. The US and Chinese markets grew rapidly.

The *Fashion & Leather Goods* business group achieved organic revenue growth of 15% * in the first nine months of 2018. Louis Vuitton continues to be driven by the success of its iconic leather goods lines and by exceptional creativity in all its businesses. Ready-to-wear and shoes, in particular, experienced strong momentum with an excellent reception of the last two fashion shows of Womenswear and Menswear. A new communication for Louis Vuitton perfumes was unveiled, marking the launch of the brand's latest perfume creation. Christian Dior Couture enjoyed an excellent performance. Celine made progress and began a new chapter in its history with the first runway show of Hedi Slimane, which was a great success and created enormous resonance. Fendi and Loro Piana continued to grow. The other brands continued to strengthen.

The *Perfumes & Cosmetics* business group recorded organic revenue growth of 14% in the first nine months of 2018, driven in particular by the performance of its star brands. Parfums Christian Dior continued its remarkable progress, driven by the launch of its new perfume Joy and the exceptional worldwide success of Sauvage and its other iconic perfumes, J'adore and Miss Dior. Rouge Dior lipstick also contributed to the performance of the House. Guerlain performed very well, with the success of Abeille Royale in skincare and Rouge G in makeup. Parfums Givenchy continued its expansion, driven by makeup and its new feminine scent L'Interdit. Fresh grew strongly.

In the first nine months of 2018, the *Watches & Jewelry* business group achieved organic revenue growth of 14%. Bvlgari had an excellent performance and gained market share. Its iconic jewelry and watch collections Serpenti, Diva, B.Zero1, Lvcea and Octo showed strong momentum; the new Wild Pop high-end jewelry line, launched at the beginning of the summer, continued to grow. Chaumet and Fred progressed steadily. In the watchmaking sector, TAG Heuer continued to develop its iconic lines. Hublot, which grew strongly, opened its first stand-alone boutique in London.

The *Selective Retailing* business group achieved organic revenue growth of 8% in the first nine months of 2018, and 14% excluding the airport concession closures in Hong Kong. Sephora's organic revenue growth was strong, particularly in North America and Asia. The expansion and renovation of its distribution network is continuing with a new store concept in China and the first Sephora-branded store in Russia. DFS performed well, especially in Hong Kong and Macao. The recent openings of T Galleria in Cambodia and Italy progressed well.

*Outlook 2018*

In an uncertain geopolitical and monetary context, the *Christian Dior group* will continue to be vigilant. The Group will pursue its strategy focused on innovation and targeted geographic expansion in the most promising markets. The Christian Dior group will rely on the power of its brands and the talent of its teams to further extend its global leadership in the luxury market in 2018.

During the quarter and to date, no events or changes have occurred which could significantly modify the Group's financial structure.

^*  Growth rate reported for this business group differs from that reported by LVMH because Christian Dior Couture was not yet included in LVMH's scope of consolidation in the first half of 2017.

*         *
***
*APPENDIX: Revenue by business group and by quarter*

This financial release constitutes regulated information, and is made available on the Company's website                 (www.dior-finance.com).

Certain information included in this release is forward-looking and is subject to important risks and uncertainties and factors beyond our control or ability to predict, that could cause actual results to differ materially from those anticipated, projected or implied. It only reflects our views as of the date of this presentation. No undue reliance should therefore be based on any such information, it being also agreed that we undertake no commitment to amend or update it after the date hereof.

This document is a free translation into English of the original French financial release dated October 9, 2018.
It is not a binding document.
In the event of a conflict in interpretation, reference should be made to the French version, which is the authentic text.

*Christian Dior group - Revenue by business group and by quarter*

*2018*              
*Revenue *(EUR millions) Wines and
Spirits Fashion and
Leather Goods Perfumes and
Cosmetics Watches and
Jewelry Selective
Retailing Other activities and eliminations *Total*
First Quarter 1,195 4,270 1,500 959 3,104 (174) *10,854*
Second Quarter 1,076 4,324 1,377 1,019 3,221 (121) *10,896*
*First Half* *2,271* *8,594* *2,877* *1,978* *6,325* *(295)* *21,750*
Third Quarter 1,294 4,458 1,533 1,043 3,219 (168) *11 379*
*Nine months* *3,565* *13,052* *4,410* *3,021* *9,544* *(463)* *33,129*
 

 

 

 

* *
*Organic revenue growth (as %)* Wines and
Spirits Fashion and
Leather Goods ^(*) Perfumes and
Cosmetics Watches and
Jewelry Selective
Retailing Other activities and eliminations *Total*
First Quarter +10% +16% +17% +20% +9% - *+14%*
Second Quarter +3% +14% +14% +12% +9% - *+11%*
*First Half* *+7%* *+15%* *+16%* *+16%* *+9%* *-* *+12%*
Third Quarter +7% +14% +11% +10% +5% - *+10%*
*Nine months* *+7%* *+15%* *+14%* *+14%* *+8%* *-* *+12%*
* * * * * * * * * * * * * * * *
* * * * * * * * * * * * * * * *
*2017* * * * * * * * * * * * * * *
*Revenue *(EUR millions) Wines and
Spirits Fashion and
Leather Goods ^(*) Perfumes and
Cosmetics Watches and
Jewelry Selective
Retailing Other activities and eliminations *Total*
First Quarter 1,196 3,911 1,395 879 3,154 (155) *10,380*
Second Quarter 1,098 ^(1) 4,035 1,275 959 3,126 (129) ^(1)* 10,364*
*First Half* *2,294* *7,946* *2,670* *1,838* *6,280* *(284)* *20 ,744*
Third Quarter 1,220 3,939 1,395 951 3,055 (179) *10,381*
*Nine months* *3,514* *11,885* *4,065* *2,789* *9,335* *(463)* *31,125*

^(1) Includes all Rimowa revenue for the first half of 2017

^* Some of the information reported by Christian Dior differs from that reported by LVMH because Christian Dior Couture was not yet included in LVMH's scope of consolidation in the first half of 2017.

*Attachment*

· Format Pdf.pdf Reported by GlobeNewswire 6 hours ago.

Pixel 3 will be available in more countries at launch

$
0
0
Pixel 3 will be available in more countries at launch Google is taking a more global approach to the Pixel 3 and Pixel 3 XL launch, announcing that it will now offer its new phones in 13 countries, including Japan, Ireland, Taiwan, and France. This builds on the rather small list of countries where Google’s Pixel 2 saw official release, which comprised of US, UK, Australia, Canada, Germany, Italy, Spain, India, and Singapore.

Now in its third generation, Google has been quite slow to bring its flagship smartphones to a wider audience, especially considering how easy it is to find a competing device, like the iPhone XS and Samsung Galaxy Note 9, practically anywhere you live. Still, its spread to more countries will give Android users more choice than before. Reported by The Verge 5 hours ago.

Arsenal Loanee David Ospina Hoping for Napoli Stay After Great Start to Season in Italy

Napoli's Diawara on choosing Guinea and denying Italy interest

$
0
0
Napoli's Diawara on choosing Guinea and denying Italy interest The Napoli midfielder previously turned down call-ups to play for Guinea, before pledging international allegiance to Syli Nationale earlier this year Reported by Goal.com 3 hours ago.

Lasagna marks Italy call with new Udinese deal

$
0
0
Kevin Lasagna has marked his first Italy call-up by signing a new contract with Udinese to 2023. Lasagna was added to the Azzurri squad as a replacement for the injured Simone Zaza on Tuesday, with Italy facing Ukraine and Poland in the coming days. And the 26-year-old capped a memorable day by putting pen to paper […]

The post Lasagna marks Italy call with new Udinese deal appeared first on Soccer News. Reported by SoccerNews.com 3 hours ago.

USD/JPY bears to have their cake and eat it? Watching China, the world growth story and US CPI this week - DXY 23.6% Fibo is key

$
0
0
· *USD/JPY has been consolidating the vicious cycle of supply from as high as 114.55 that has formed in a spiral of offers since Oct. 3rd down to a low of 112.82 when the pair broke below the key support line of the 23.6% Fibo. *
· *The pair dropped below the pivot and came into the 38.2% zone, 112.97, with sell stop slippage occurring to mark the aforementioned low.  *

The price has since accumulated here with lower lows and a higher corrective high to 113.39. The bulls have some work to do if they are to convince with a break above R1 located at 113.77. Such an achievement will be a tall order considering we are in a climate of poor risk appetite. 

Just recently, as already well telegraphed, the IMF cut its global growth forecast from 3.9% to 3.7%, noting the ongoing trade tensions. Earlier today, Trump was reported saying that the Chinese are not ready to come to the negotiating table - "Not ready to make a deal", where his exact words. However, White House CEA Chair, Hassett, said that he sees a lot of progress with Europe on trade. But trade is just the half of it. 

*Eyes on China's 'CSI 300 Index'*

While there is a big focus on Italy and Brexit, the European banking, it is emerging markets and China risk that should be considered as like a time bomb. The Hang Seng is already at multi-year lows and the recent 4.3% sell-off in the China 300 was a three Z-score event.  We also have USD/CNH in the troublesome territory for EM-FX, even while the Chinese authorities have been cutting Reserve Ratio Requirement’s by 100 basis points - yet, still, the CNH is on the floor - A telling sign that sentiment in the market is not about to change and that should be Yen bullish on Japanese repatriation flows alone. Eyes are also on the CSI 300 index.  3,200 as a floor - Another break there as we saw in mid-late Sep, but with a subsequent follow through, (often takes a few attempts for key levels to break), all hell could break loose in global equities and that could also spell trouble for USD/JPY bulls. However, with respect to EMs, the dollar shortfall had been something that was giving the greenback a boost, so without the support of a synchronised growth pact on a global macro basis, then the dollar may still shine once the yen repatriation flows dry up and once it has found a fair value with respect to the economic divergence between the US and Japanese growth story. Indeed, the US/JP spread will likely come back to the fore in favour of the dollar. 

*US CPI, US yields and DXY in focus*

Indeed, the focus will be on the US CPI data this week as well as US fixed income. We have a very large $230b in paper being auction this week alone - Such supply could elevate US yields even higher. However,  there has been a decoupling between the DXY and US yields of late. What bulls want to see is the DXY break that key 96.240 Fibonacci level, a 76.4 percent retrace of the 96.991 to 93.808 (August to September) decline. Depending on the outcome of the US CPI this week, should the dollar fail to play catch up with yields and be unable to cross over this critical level, USD/JPY bears could well have their cake and eat it, for now, with an unwinding of an overcrowded dollar speculative long position. 

Analysts at Nomura noted the key US CPI this week offered a preview (Key event for the week: US CPI - Nomura):

*Key Quotes:*

"CPI (Thursday): We forecast 0.2% (0.244%) m-o-m increase in core CPI inflation for September following a 0.082% advance in August. On a 12-month change basis, our forecast would be equivalent to 2.304% advance in September, up slightly from a 2.190% pace in August. The relative softness in core CPI inflation in August was mostly concentrated certain volatile core goods prices."

*USD/JPY levels*

· Support levels: 112.80 112.50 112.20
· Resistance levels: 113.40 113.75 114.10

Valeria Bednarik, Chief Analyst at FXStreet, explained that the pair has spent the day hovering around a mild-bullish 100 SMA in its 4 hours chart, losing ground below it in the American afternoon:

"Technical indicators resume their declines well into negative territory following a correction of oversold conditions, in line with further declines, particularly on a break below Monday's low at 112.81, with scope then to  extend its decline down to 112.00/20."
 

  Reported by FXstreet.com 3 hours ago.

The Malta Philharmonic Orchestra (MPO) Celebrates its 50th Anniversary with a Three City US Tour

$
0
0
MPO Valletta 2018 Tour - Philadelphia - Washington D.C. - New York - November 27- December 1, 2018

New York, New York, Oct. 09, 2018 (GLOBE NEWSWIRE) -- The Malta Philharmonic Orchestra (MPO) will be embarking on its first US tour, the *MPO Valletta 2018 Tour*, celebrating both their 50th Anniversary and the World Heritage UNESCO site, Valletta, the European Capital of Culture 2018. The MPO will be led by the famous conductor Sergey Smbatyan, Honored Artist of the Republic of Armenia who frequently appears with MPO.

This project was initiated and implemented by the European Foundation for Support of Culture (EUFSC) together with the Malta Philharmonic Orchestra, endorsed by the Valletta 2018 Foundation and supported by the Embassy of the Republic of Malta to the USA and the Malta Tourism Authority. The EUFSC has a very vast portfolio of projects and events which are organized in Malta and abroad, with an extensive calendar especially during the past three years.The first US Tour follows a successful two years in which the MPO has collaborated with numerous orchestras and opera companies and performed in leading venues across the globe, including in China, Italy, Germany, Austria, and Belgium

The MPO Valletta 2018 Tour will start in Philadelphia on November 27^th at the renowned Kimmel Center for the Performing Arts; proceed to North Bethesda on November 29^th at the Music Center at Strathmore - Washington DC, and their final stop will be in New York City on December 1^st at Carnegie Hall. The concerts will be attended to by H.E. Keith Azzopardi, Ambassador of Malta to the United States of America and H.E. Carmelo Inguanez, Permanent Representative of Malta to the United Nations.

Each concert will begin with a performance of Rebbieħa, a symphonic poem penned by Gozitan composer Joseph Vella.

The MPO will then continue with the work of famous modern American-Maltese composer, Alexey Shor, with Austrian pianist Ingolf Wunder (prize-winner of many international competitions, Deutsche Grammophon artist) as a soloist, before rounding off its concerts with Dmitri Shostakovich’s famous Fifth Symphony.

Michelle Buttigieg, Malta Tourism Authority North American Representative noted that "The timing for this inaugural debut of the Malta Philharmonic Orchestra in the United States underscores Malta's cultural sophistication and diverse offerings at a time when we are experiencing a dramatic increase in tourism to the Maltese Islands from the US Market." 

*-ENDS-*

*For Booking:*

*November 27, 2018- Kimmel Center, Philadelphia, Pennsylvania: *https://www.kimmelcenter.org/events-and-tickets/201819/rentals/malta-philharmonic-orchestra/

*November 29, 2018- The Music Center at Strathmore, North Bethesda, Maryland: *https://www.strathmore.org/events-and-tickets/mpo-valletta-tour

*December 1, 2018- Carnegie Hall, New York, New York: *https://www.carnegiehall.org/Calendar/2018/12/01/Malta-Philharmonic-Orchestra-0600PM

*About the European Foundation for Support of Culture
*http://eufsc.eu/

***About the Malta Philharmonic Orchestra
***http://www.maltaorchestra.com/

*About Malta
*The sunny islands of Malta, in the middle of the Mediterranean Sea, are home to a most remarkable concentration of intact built heritage, including the highest density of UNESCO World Heritage Sites in any nation-state anywhere.  Valletta built by the proud Knights of St. John is one of the UNESCO sights and the European Capital of Culture for 2018. Malta's patrimony in stone ranges from the oldest free-standing stone architecture in the world, to one of the British Empire's most formidable defensive systems, and includes a rich mix of domestic, religious and military architecture from the ancient, medieval and early modern periods. With superbly sunny weather, attractive beaches, a thriving nightlife and 7,000 years of intriguing history, there is a great deal to see and do. www.visitmalta.com

*For Further Information:*

*MTA US Editorial Contact:
*The Bradford Group
Karen Hoffman/ Bianca Pappas
Tel: (212) 447-0027
Fax: (212) 725 8253
E-mail: info@bradfordglobalmarketing.com

*Attachments*

· European Foundation for Support of Culture
· Malta Philharmonic Orchestra

CONTACT: Michelle Buttigieg
Malta Tourism Authority
212 213 0944
michelle-margaret.buttigieg@visitmalta.com Reported by GlobeNewswire 2 hours ago.

Calgary Selected as Candidate City for 2026 Olympic and Paralympic Winter Games

$
0
0
Calgarians will continue to be informed and engaged

CALGARY, ALBERTA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- Calgary 2026 Bid Corporation (BidCo) has announced that Calgary has been selected by the International Olympic Committee (IOC) as a Candidate City for the 2026 Olympic and Paralympic Winter Games.  The announcement was made today in Buenos Aires at a meeting of IOC Committee members during the Youth Olympic Games.  This development now allows Calgary to officially enter the candidature to host the Games.“This announcement moves us one step forward in the bid process but there is still lots of work to be done,” said Scott Hutcheson, Calgary 2026 BidCo Chair.  “Our focus remains on informing Calgarians about our plan to host the 2026 Olympic and Paralympic Winter Games to see how we might shape the Games, and the future of Calgary, together.”“We are both honoured and thrilled by the decision of the IOC in Buenos Aires today designating Calgary as a candidate city and finalist for the 2026 Olympic Winter Games.  This is a very encouraging, hopeful step forward to bringing the Games back to Canada,” said Tricia Smith, President of the Canadian Olympic Committee.We also congratulate fellow finalists Stockholm (Sweden) and Milan/Cortina/d’Ampezzo (Italy).  This will be a year to remember for all three cities.“Memories of Calgary 1988 and Vancouver 2010 continue to fill us all with pride and I know Canadians everywhere are now cheering Calgary on with hopes for the next generation of young Canadians who dream big and aspire to be our next Olympians,” concluded Smith.“This is an important step of many in the process to bring the Olympic and Paralympic Games to Calgary,” said Marc-André Fabien, Canadian Paralympic Committee President.  “We believe Calgary is the perfect city to showcase sport on a global stage, and are very excited to continue our collaborative work with all parties involved to create an inclusive and accessible Games that will leave a lasting impact on sport development in Canada.”CEO Mary Moran and the team at Calgary 2026 hope to win the right to host the Olympic and Paralympic games again because it is a rare opportunity to help reach some important goals: Indigenous reconciliation, support economic prosperity, build a positive brand for Calgary, Canmore and Canada in an era of divisiveness globally, and construct badly needed affordable housing and community sports venues and renew others.“Hosting the Games is a rare opportunity to strengthen our communities by renewing facilities and building new ones that everyone can benefit from,” said Mary Moran, Calgary 2026 BidCo Chief Executive Officer.  “We have a chance to create a legacy that will benefit our younger generation for decades to come.”Calgary 2026 continues to meet with stakeholders and members of the public daily, sharing the facts of the draft hosting plan that was released to the public in mid-September.  Community engagement will continue to increase, giving Calgarians and members of the broader community in Banff and Canmore an opportunity to ask questions, share their concerns and learn more about the 2026 bid.Calgarians will vote November 13th, answering the question: are you for or are you against Calgary hosting the 2026 Olympic and Paralympic Winter Games?
The final decision of the IOC members for the host of the 2026 Olympic and Paralympic Winter Games will take place in Lausanne, Switzerland at the IOC Session at the end of June 2019.

 

-30-

 

For more information contact: 

James Millar, Director, Communications & Media Relations, Calgary 2026 BidCo
403.891.2026
jmillar@calgary2026.ca

 

ABOUT CALGARY 2026 The mandate of Calgary 2026 Bid Corporation is to support and promote the development of sport and amateur athletics in Canada through the development and promotion of a bid to hold the 2026 Olympic and Paralympic Winter Games in the City of Calgary, the Town of Canmore and surrounding and other areas as needed to host the Games and, in particular, to develop, co-ordinate and present to the International Olympic Committee a bid to have the City of Calgary named as the host city to stage the Games.

*Attachment*

· News release - Calgary selected as Candidate City for 2026 Games - October 9-18 1230 FINAL ENG

CONTACT: James Millar
Calgary 2026
1-403-891-2026
jmillar@calgary2026.ca Reported by GlobeNewswire 2 hours ago.

DiaSorin and Meridian Enter Into a Strategic Collaboration to Sell Helicobacter Pylori Stool Antigen Test in the United States and in the United Kingdom

$
0
0
SALUGGIA, Italy and CINCINNATI, Oct. 09, 2018 (GLOBE NEWSWIRE) -- *DiaSorin* *S.p.A.* (FTSE Italy Mid Cap: DIA) and *Meridian Bioscience, Inc*. (NASDAQ:VIVO) today announced that DiaSorin Inc., a subsidiary of DiaSorin S.p.A. and Meridian Bioscience, Inc. have entered into a strategic collaboration to sell DiaSorin’s FDA-cleared Helicobacter pylori stool antigen test to detect H. pylori for use on its automated LIAISON platform under the Meridian brand name worldwide. As part of this agreement, Meridian and DiaSorin will begin collaborating on sales and marketing efforts to hospitals and reference laboratories in the U.S. Moreover, Meridian will receive royalties on sales of the LIAISON H. pylori stool antigen test in the U.S. and now also in the UK, in addition to the royalties received under the previous agreement.

This new collaboration will result in the termination of all pending legal disputes and will expand the scope of the previous agreement between DiaSorin and Meridian, which focused on the sale, by DiaSorin, of co-developed products in major countries in continental Europe. 

Helicobacter pylori is one of the most common bacterial infections in humans, affecting nearly 50% of the world’s population and it has been associated with the development of serious upper gastrointestinal (GI) conditions including chronic gastritis, peptic ulcer disease, gastric cancer, and mucosa-associated lymphoid tissue (MALT).

Additionally, Meridian and DiaSorin have outlined a framework where they may partner to develop other stool-based tests for use on the LIAISON platform.

*Carlo Rosa*,* Chief Executive Officer at DiaSorin*, commented “We are pleased to enter into this collaboration with Meridian Bioscience. Our stool testing products have been very successful and we are confident that, through this alliance with Meridian, we can continue to expand the adoption of our automated LIAISON platform and its large menu of tests in key markets, like the U.S. and UK. This collaboration creates synergies between state-of-the-art products and technology, which will result in expanded access to a fully automated test for the detection of H. pylori antigen in stool. Moreover, I’m confident that DiaSorin and Meridian will be able to develop additional stool-based tests, leveraging a reliable technology, a broad menu offer for the clients and a large chemiluminescent platform installed base worldwide.”

*Jack Kenny, Chief Executive Officer at Meridian Bioscience*, continued, “We are excited to team up with DiaSorin to facilitate the advancement of automated HpSA testing. Working together with DiaSorin, we believe we can accelerate the growth in testing to detect helicobacter pylori, a cause of stomach ulcers. Importantly, today many patients suffering from stomach ulcers are not tested, or are tested with less effective serology methods. Non-invasive stool testing platforms are highly accurate and cost effective. Furthermore, these tests can be used in the monitoring and testing of eradication of the H. pylori infection. DiaSorin and Meridian have enjoyed a collaborative relationship for almost ten years. I look forward to further strengthening this relationship as we embark upon this new partnership.”

*About DiaSorin Group*

Headquartered in Italy and listed in the FTSE Mid Cap Index, DiaSorin is a global leader in the In Vitro Diagnostic (IVD) field. For over 50 years the Company has been developing, producing and marketing reagent kits for IVD worldwide. Through constant investments in research and development, and using its own distinctive expertise in the field of immunodiagnostics to deliver a high level of innovation, DiaSorin offers today the broadest range of specialty tests available in the immunodiagnostics market and new tests in the molecular diagnostics markets, which identify DiaSorin Group as the IVD “Diagnostic Specialist.”

More info at www.diasorin.com

*About Meridian Bioscience, Inc.*

Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com

*FORWARD-LOOKING STATEMENTS*

The Private Securities Litigation Reform Act of 1995 provides a safe harbor from civil litigation for forward-looking statements accompanied by meaningful cautionary statements.  Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, which may be identified by words such as “estimates”, “anticipates”, “projects”, “plans”, “seeks”, “may”, “will”, “expects”, “intends”, “believes”, “should” and similar expressions or the negative versions thereof and which also may be identified by their context.  All statements that address operating performance or events or developments that Meridian expects or anticipates will occur in the future, including, but not limited to, statements relating to per share diluted earnings and revenue, are forward-looking statements. Such statements, whether expressed or implied, are based upon current expectations of the Company and speak only as of the date made.  Specifically, Meridian’s forward-looking statements are, and will be, based on management’s then-current views and assumptions regarding future events and operating performance.  Meridian assumes no obligation to publicly update or revise any forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized.  These statements are subject to various risks, uncertainties and other factors that could cause actual results to differ materially, including, without limitation, the following:

Meridian’s operating results, financial condition and continued growth depends, in part, on its ability to introduce into the marketplace enhancements of existing products or new products that incorporate technological advances, meet customer requirements and respond to products developed by Meridian’s competition, its ability to effectively sell such products and its ability to successfully expand and effectively manage increased sales and marketing operations.  While Meridian has introduced a number of internally developed products, there can be no assurance that it will be successful in the future in introducing such products on a timely basis or in protecting its intellectual property, and unexpected or costly manufacturing costs associated with the ramp up of new products could cause actual results to differ from expectations.  Meridian relies on proprietary, patented and licensed technologies.  As such, the Company’s ability to protect its intellectual property rights, as well as the potential for intellectual property litigation, would impact its results.  Ongoing consolidations of reference laboratories and formation of multi-hospital alliances may cause adverse changes to pricing and distribution.  Recessionary pressures on the economy and the markets in which our customers operate, as well as adverse trends in buying patterns from customers, can change expected results.  Costs and difficulties in complying with laws and regulations, including those administered by the United States Food and Drug Administration, can result in unanticipated expenses and delays and interruptions to the sale of new and existing products, as can the uncertainty of regulatory approvals and the regulatory process.  The international scope of Meridian’s operations, including changes in the relative strength or weakness of the U.S. dollar and general economic conditions in foreign countries, can impact results and make them difficult to predict.  One of Meridian’s growth strategies is the acquisition of companies and product lines.  There can be no assurance that additional acquisitions will be consummated or that, if consummated, will be successful and the acquired businesses will be successfully integrated into Meridian’s operations.  There may be risks that acquisitions may disrupt operations and may pose potential difficulties in employee retention, and there may be additional risks with respect to Meridian’s ability to recognize the benefits of acquisitions, including potential synergies and cost savings or the failure of acquisitions to achieve their plans and objectives.  Meridian cannot predict the outcome of goodwill impairment testing and the impact of possible goodwill impairments on Meridian’s earnings and financial results.  Meridian cannot predict the possible impact of U.S. health care legislation enacted in 2010 – the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act – and any modification or repeal of any of the provisions thereof initiated by Congress or the presidential administration, and any similar initiatives in other countries on its results of operations.  Efforts to reduce the U.S. federal deficit, breaches of Meridian’s information technology systems, and natural disasters and other events could have a materially adverse effect on Meridian’s results of operations and revenues.  In the past, the Company has identified a material weakness in our internal control over financial reporting, which has been remediated, but the Company can make no assurances that a material weakness will not be identified in the future, which if identified and if not properly corrected, could materially adversely affect our operations and result in material misstatements in our financial statements.  In addition to the factors described in this paragraph, as well as those factors identified from time to time in our filings with the Securities and Exchange Commission, Part I, Item 1A Risk Factors of our most recent Annual Report on Form 10-K contains a list and description of uncertainties, risks and other matters that may affect the Company.  Readers should carefully review these forward-looking statements and risk factors, and not place undue reliance on our forward-looking statements.

*For additional information, please contact:*

*Riccardo Fava* *Ines Di Terlizzi*
Investor Relations & Corporate Communication Senior Director Investor Relator
DiaSorin S.p.A.  DiaSorin S.p.A.
Tel: +39.0161.487988 Tel: +39.0161.487567 
riccardo.fava@diasorin.it ines.diterlizzi@diasorin.it
   
*Jack Kenny*  
Chief Executive Officer  
Meridian Bioscience, Inc.  
Phone:  513.271.3700  
Email: mbi@meridianbioscience.com  

  Reported by GlobeNewswire 1 hour ago.

Tax Lawyer Ben Eaton to Join Greenberg Traurig in London, Adds Strength to Growing Real Estate Team

$
0
0
The London office of global law firm Greenberg Traurig, LLP continues the strategic expansion of its real estate sector team with the addition of investment funds and real estate sector tax specialist Ben Eaton, who is set to join the firm in November.

NEW YORK (PRWEB) October 09, 2018

The London office of global law firm Greenberg Traurig, LLP continues the strategic expansion of its real estate sector team with the addition of investment funds and real estate sector tax specialist Ben Eaton, who is set to join the firm in November.

“Greenberg Traurig is excited to share Ben’s announcement that he will leave Goodwin Procter to join us as a shareholder in London, working with the team that has been responsible for landmark transactions in the real estate sector in London during the past 18 months or so,” said Richard A. Rosenbaum, Greenberg Traurig’s Executive Chairman. “Ben’s legal practice is a natural fit in that he is aligned with our firm’s core values and strategies that have served us well as we have grown this team in a strategic and disciplined manner, even in today’s disruptive environment.”

In early 2017, Greenberg Traurig’s London office added a senior group of highly regarded shareholders and their teams, who focus on the real estate sector, which enhanced its pan-European offering across its offices in The Netherlands, Germany, the UK, and Central and Eastern Europe, and a strong, strategic alliance in Italy.

Eaton focuses his practice on the tax aspects of real estate transactions and investment funds, with an emphasis on cross-border work. He has deep experience advising on the tax aspects of real estate investment, and financing, development, as well as structuring of funds and joint ventures, investing in real estate and real estate debt, and transactions involving real estate operating businesses. According to the Legal 500 UK, Eaton “has ‘outstanding knowledge of foreign tax systems and is able to use that knowledge to provide multijurisdictional structuring advice.’”

“While working primarily in the real estate sector,” Eaton said, “I also advise clients on the tax aspects of private equity transactions and funds investing in other asset classes. Much of my work involves advising on international tax issues associated with cross-border investment. Greenberg Traurig’s strong reputation in this area and award-winning real estate team sealed my decision to join.”

"We have been focused on building the leading real estate practice in the world, and the team has become more robust by the firm's commitment to simultaneously increasing our resources in key synergistic areas such as tax, private equity and fund formation,” noted Real Estate Practice Co-Chairs Robert J. Ivanhoe, Corey E. Light, and Richard J. Giusto in a joint statement. “Ben’s addition reflects the importance of related tax expertise to the real estate sector. Our ability to handle complex deals for our clients around the globe and in the active London market will be enhanced by Ben’s experience and expertise, particularly given his natural cultural fit with GT and our team.”

Greenberg Traurig’s top ranking pan-European real estate sector team now has about 160 lawyers.

Eaton is listed in The Legal 500 UK. He serves as chairman of The Law Society’s Stamp Taxes Sub-Committee and as a member of its Main Tax Committee. He is an associate member of the British Property Federation Tax Committee, the Stamp Taxes Practitioners Group, and a former member of the Investment Management Association Tax Committee. Eaton received an LL.M. from the University of Cambridge Selwyn College in 1993; attended the Law Society Finals at The College of Law in Chester in 1992; and received his M.A. from University of Cambridge in 1991. He is admitted to practice in England and Wales.

About Greenberg Traurig's Real Estate Practice: The Greenberg Traurig Real Estate Practice is a cornerstone of the firm and recognized leader in the industry. The firm’s real estate attorneys deliver diversified and comprehensive counsel for property acquisition and investment, development, management and leasing, financing, restructuring, and disposition of all asset classes of real estate. The team draws upon the knowledge and experience of more than 400 real estate lawyers from around the world, serving clients from key markets in the United States, Europe, the Middle East, Latin America and Asia. The group’s clientele includes a broad range of property developers, lenders, investment managers, private equity funds, REITs, and private owners. The firm’s real estate team advises clients on a variety of matters across a broad spectrum of commercial, recreational, and residential real estate, including structured equity and debt and the hybrids.

About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 38 offices in the United States, Latin America, Europe, Asia and the Middle East. GT has been recognized for its philanthropic giving, was named the largest firm in the U.S. by Law360 in 2017, and is among the Top 20 on the 2018 Am Law Global 100. Web:http://www.gtlaw.com Twitter: @GT_Law. Reported by PRWeb 56 minutes ago.

IOC approves 2026 Winter Oly candidates

$
0
0
Canada's Calgary, Italy's Milan and Sweden's Stockholm will compete as host cities for the 2026 Winter Olympics, the IOC has confirmed. Reported by SBS 13 minutes ago.

Joe Giudice from "RHONJ" will be deported to Italy

$
0
0
"Real Housewives of New Jersey" star Joe Giudice is likely headed back to Italy after his release from prison Reported by CBS News 1 hour ago.

Joe Giudice could be deported to Italy when he is released from jail

$
0
0
The reality-TV star -- serving a 41-month conviction for fraud -- has a month to appeal a judge's decision. Reported by Newsday 1 hour ago.

K2M Receives FDA Clearance Including Surgical Guidance that Enhances MESA® Platform Using Patient-Specific Rods & Rails

$
0
0
Dual Differential Correction (DDC™) Philosophy & Technique helps restore sagittal balance in patients

LEESBURG, Va., Oct. 10, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance^™, today announced at the Scoliosis Research Society 53^rd Annual Meeting & Course, in Bologna, Italy a U.S. Food and Drug Administration (FDA) 510(k) clearance that also provides for the Dual Differential Correction (DDC^™) Philosophy & Technique. The DDC philosophy combines rod rigidity and degree of bend with the MESA^® Platform Technology, to help achieve quality outcomes in patients with sagittal imbalance. In addition, MESA can be used with the BACS^® Patient-Specific Rods to help surgeons create pre-contoured rods, rails, and templates that match the surgeon’s preoperative plan.Todd Ritzman, MD, Akron Children’s Hospital, explained, “Given the growing recognition of the importance of sagittal plane correction in idiopathic scoliosis, it is a valuable aid to objectively determine rod contour based off of a given patient’s pelvic incidence to help optimize surgical correction in the sagittal plane. The days of ‘eyeballing’ the rod contour are over.”

K2M’s MESA Platform Technology features top-loading and low-profile screws and Zero-Torque Technology^® that one-step locks without applying torsional stress to the spine. The MESA Platform includes the MESA 2 Deformity Spinal System, a state-of-the-art solution for the most difficult correction maneuvers in complex spine surgery.

K2M manufactures BACS Patient-Specific Rods and Rails using a machine rolling method, replacing the manual three-point bending method that often reduces rod fatigue strength. By incorporating data from BACS Surgical Planner—part of K2M’s comprehensive BACS Digital Platform— rods and rails can be manufactured with complex multi-contoured designs. BACS Patient-Specific Rods and Rails can be used with the MESA, EVEREST^®, and DENALI^® Spinal Systems.

BACS provides solutions focused on achieving balance of the spine by addressing each anatomical vertebral segment with a 360-degree approach to the axial, coronal, and sagittal planes, emphasizing Total Body Balance as an important component of surgical success.

*K2M to Appear at SRS 2018 *

At the meeting, K2M executives will be onsite to discuss the Company’s differentiated spinal solutions, including its MESA Platform Technology, 3D-printed devices featuring Lamellar 3D Titanium Technology^™, and comprehensive Balance ACS^® (BACS) Platform.

“K2M is a proud Double Diamond Sponsor of SRS 2018,” said John P. Kostuik, MD, Chief Medical Officer, Co-founder, and Member of the Board of Directors at K2M, and Past President of the SRS. “This year, we are excited to build upon our culture of innovation by showcasing our leading spinal solutions, most notably our Dual Differential Correction Philosophy & Technique—used in conjunction with our world-class MESA Platform Technology and Balance ACS Platform—so surgeons can correct complex spinal deformities across all three anatomical planes and help eliminate the need for further derotation maneuvers.”

For more information on K2M and Balance ACS, visit www.K2M.com and www.BACS.com.

*About K2M*

K2M Group Holdings, Inc. is a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance. Since its inception, K2M has designed, developed, and commercialized innovative complex spine and minimally invasive spine technologies and techniques used by spine surgeons to treat some of the most complicated spinal pathologies. K2M has leveraged these core competencies into Balance ACS, a platform of products, services, and research to help surgeons achieve three-dimensional spinal balance across the axial, coronal, and sagittal planes, with the goal of supporting the full continuum of care to facilitate quality patient outcomes. The Balance ACS platform, in combination with the Company’s technologies, techniques and leadership in the 3D-printing of spinal devices, enable K2M to compete favorably in the global spinal surgery market. For more information, visit www.K2M.com and connect with us on Facebook, Twitter, Instagram, LinkedIn and YouTube.

*Forward-Looking Statements*

The foregoing contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.  We intend for these forward-looking statements to be covered by the safe harbor provisions of the federal securities laws relating to forward-looking statements.  These forward-looking statements include statements relating to the expected timing, completion and effects of the proposed merger, as well as other statements representing management’s beliefs about, future events, transactions, strategies, operations and financial results, including, without limitation, our expectations with respect to the costs and other anticipated financial impacts of the merger; future financial and operating results of K2M Group Holdings, Inc. (“K2M”); K2M’s plans, objectives, expectations and intentions with respect to future operations and services; required approvals to complete the merger by our stockholders and by governmental regulatory authorities, and the timing and conditions for such approvals; the stock price of K2M prior to the consummation of the transactions; and the satisfaction of the closing conditions to the proposed merger.  Such forward-looking statements often contain words such as “assume,” “will,” “anticipate,” “believe,” “predict,” “project,” “potential,” “contemplate,” “plan,” “forecast,” “estimate,” “expect,” “intend,” “is targeting,” “may,” “should,” “would,” “could,” “goal,” “seek,” “hope,” “aim,” “continue” and other similar words or expressions or the negative thereof or other variations thereon.  Forward-looking statements are made based upon management’s current expectations and beliefs and are not guarantees of future performance.  Such forward-looking statements involve numerous assumptions, risks and uncertainties that may cause actual results to differ materially from those expressed or implied in any such statements.  Our actual business, financial condition or results of operations may differ materially from those suggested by forward-looking statements as a result of risks and uncertainties which include, among others, those risks and uncertainties described in any of our filings with the Securities and Exchange Commission (the “SEC”).  Certain other factors which may impact our business, financial condition or results of operations or which may cause actual results to differ from such forward-looking statements are discussed or included in our periodic reports filed with the SEC and are available on our website at www.K2M.com under “Investor Relations.” You are urged to carefully consider all such factors.  Although it is believed that the expectations reflected in such forward-looking statements are reasonable and are expressed in good faith, such expectations may not prove to be correct and persons reading this communication are therefore cautioned not to place undue reliance on these forward-looking statements which speak only to expectations as of the date of this communication.  We do not undertake or plan to update or revise forward-looking statements to reflect actual results, changes in plans, assumptions, estimates or projections, or other circumstances occurring after the date of this communication, even if such results, changes or circumstances make it clear that any forward-looking information will not be realized.  If we make any future public statements or disclosures which modify or impact any of the forward-looking statements contained in or accompanying this communication, such statements or disclosures will be deemed to modify or supersede such statements in this communication.

*Additional Information and Where to Find It*

This communication does not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities or a solicitation of any vote or approval.  In connection with this proposed acquisition, K2M has filed a definitive proxy statement and has filed or may file other documents with the SEC.  This communication is not a substitute for any proxy statement or other document K2M has filed or may file with the SEC in connection with the proposed transaction.  INVESTORS AND SECURITY HOLDERS OF K2M ARE URGED TO READ THE PROXY STATEMENT AND OTHER DOCUMENTS THAT HAVE BEEN (OR MAY BE) FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION.  The definitive proxy statement will be mailed to stockholders of K2M.  Investors and security holders may obtain free copies of these documents and other documents filed with the SEC by K2M through the website maintained by the SEC at www.sec.gov.  Copies of the documents filed with the SEC by K2M will be available free of charge on K2M’s internet website at www.K2M.com or upon written request to: Secretary, K2M Group Holdings, Inc., 600 Hope Parkway, SE, Leesburg, Virginia 20175, or by telephone at (703) 777-3155.

*Participants in Solicitation*

K2M, its directors and certain of its executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction.  Information regarding the persons who may, under the rules of the SEC, be deemed participants in such solicitation in connection with the proposed merger will be set forth in the definitive proxy statement filed with the SEC on October 5, 2018.  Information about the directors and executive officers of K2M is set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2017, which was filed with the SEC on March 1, 2018, its proxy statement for its 2018 annual meeting of stockholders, which was filed with the SEC on April 20, 2018, its Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2018 and June 30, 2018, which were filed with the SEC on May 2, 2018 and August 2, 2018, respectively, and its Current Reports on Form 8-K or Form 8-K/A, which were filed with the SEC on January 8, 2018, January 9, 2018, February 28, 2018, March 29, 2018, May 1, 2018, June 11, 2018, June 14, 2018, June 18, 2018, August 1, 2018, August 30, 2018, and October 5, 2018.

These documents can be obtained free of charge from the sources indicated above.  Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, is contained in the definitive proxy statement and other relevant materials filed with the SEC.

K2M Group Holdings, Inc.
600 Hope Parkway, SE
Leesburg, Virginia 20175
Tel. (703) 777-3155
www.K2M.com

Media Contact:
         Zeno Group on behalf of K2M Group Holdings, Inc.
         Christian Emering, 212-299-8985
         Christian.Emering@ZenoGroup.com 

Investor Contact:
         Westwicke Partners on behalf of K2M Group Holdings, Inc.
         Mike Piccinino, CFA, 443-213-0500
         K2M@westwicke.com Reported by GlobeNewswire 1 hour ago.

Italy 1 Ukraine 1: Mancini's winless run stretches to five games

$
0
0
Ruslan Malinovskiy's second-half volley for Ukraine means Roberto Mancini has still only recorded one win in charge of Italy. Reported by Goal.com 46 minutes ago.

Genoa bridge victims honoured in Italy friendly

$
0
0
Genoa bridge victims honoured in Italy friendly Italy are held to a draw by Ukraine on an emotional night at Sampdoria's Stadio Luigi Ferraris which remembered the victims of the bridge collapse in Genoa. Reported by BBC Sport 1 hour ago.
Viewing all 40166 articles
Browse latest View live


Latest Images